26-Aug-2019: The global rabies
diagnostics market size is expected to reach USD 2.03
billion by 2025 and is projected to expand at a CAGR of 4.1% during the
forecast period, according to a new report by Grand View Research, Inc.
Development of various diagnostic assays ranging from detection of virus
presence to final confirmation of infection helps launch effective disease
control programs. This factor is anticipated to drive the market growth. These
assays aid in defining epidemiologic patterns of the disease and thereby
deliver appropriate information for designing the control and eradication
programs. These programs have boosted the market growth by increasing the rate
at which testing kits are adopted.
For example, in
June 2018, the World Health Organization (WHO), the World Organization for
Animal Health (OIE), the Global Alliance for Rabies Control (GARC), and the
Food and Agriculture Organization of the United Nations (FAO) entered into a
partnership for a plan, The United Against Rabies Collaboration. This plan aims
for rabies prevention and management and empowering the under-served
populations in afflicted countries.
Furthermore, the
state and public health officials of the Department of Public Health and Human
Services (DPHHS) along with the Department of Livestock of Montana, U.S., deal
with awareness pertaining to the risk of virus exposure. They are engaged in
training the population about various aspects of disease management including
prevention, detection, and available treatment modes. Such initiatives are
projected to create growth opportunities for the rabies diagnostics market
during the forecast period.
In
depth research report on Rabies Diagnostics Market
Further key findings from the report suggest:
·
Fluorescent Antibody Test (FAT) held the largest market share
in terms of revenue owing to the high usage and recommendation by the WHO.
Great specificity, as compare to other conventional tests such as serology and
histology tests bodes well for the adoption of these tests
·
Amplification methods are expected to supplant a major
portion of conventional methods, primarily due to several advantages associated
with the usage
·
Currently, major products deploy ELISA/immunohistochemistry
techniques, resulting into a larger revenue share of this segment
·
High prevalence of the disease in India and China coupled
with growing government support has contributed to the dominance of Asia market
over other regions
·
Since, most of the countries in Europe are designated as
rabies free jurisdictions, the Europe market is anticipated to grow at the
slowest pace over the forecast period
·
Bio-Rad Laboratories, Inc.; Merck KGaA; Aviva Systems Biology
Corporation; and Creative Diagnostics are some of the key entities in the
rabies testing market. The companies engage in developing products for rabies
eradication programs.
Grand View Research
has segmented the global rabies diagnostics market on the basis of diagnostic
method, technology, and region:
Rabies Diagnostics Diagnostic Method Outlook (Revenue, USD
Million, 2014 - 2025)
·
Fluorescent antibody test (FAT)
·
Immunohistochemical test
·
Amplification methods
·
Histologic examination
·
Serology tests
Rabies Diagnostics Technology Outlook (Revenue, USD Million,
2014 - 2025)
·
ELISA/Immunohistochemistry
·
Chromatography techniques
·
PCR
·
Others
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. in the
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment